EP0696319B1 - Ein enzym mit pektin methylesteraseaktivität - Google Patents

Ein enzym mit pektin methylesteraseaktivität Download PDF

Info

Publication number
EP0696319B1
EP0696319B1 EP94914350A EP94914350A EP0696319B1 EP 0696319 B1 EP0696319 B1 EP 0696319B1 EP 94914350 A EP94914350 A EP 94914350A EP 94914350 A EP94914350 A EP 94914350A EP 0696319 B1 EP0696319 B1 EP 0696319B1
Authority
EP
European Patent Office
Prior art keywords
enzyme
pectin
dna
cell
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP94914350A
Other languages
English (en)
French (fr)
Other versions
EP0696319A1 (de
Inventor
Stephan Christgau
Lene Venke Kofod
Lene Nonboe Andersen
Sakari Kauppinen
Hans Peter Heldt-Hansen
Gitte Budolfsen
Henrik Dalboege
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK48793A external-priority patent/DK48793D0/da
Priority claimed from DK121793A external-priority patent/DK121793D0/da
Application filed by Novozymes AS filed Critical Novozymes AS
Publication of EP0696319A1 publication Critical patent/EP0696319A1/de
Application granted granted Critical
Publication of EP0696319B1 publication Critical patent/EP0696319B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)

Definitions

  • the present invention relates to an enzyme with pectin methylesterase (PME) activity, a DNA construct encoding the enzyme, a method of producing the enzyme, an enzyme preparation containing the enzyme and various uses of the enzyme.
  • PME pectin methylesterase
  • Pectin polymers are important constituents of plant primary cell walls. They are mainly composed of chains of 1,4-linked ⁇ -D-galacturonic acid and methylated as well as acetylated derivatives thereof.
  • the use of pectin-degrading enzymes is important in the food industry, primarily for fruit and vegetable processing such as fruit juice production or wine making, where their ability to catalyse the degradation of the backbone of the pectin polymer is utilised.
  • pectin degrading enzymes catalyses the removal of methanol from pectin, resulting in the formation of pectic acid (polygalacturonic acid).
  • pectate lyase cleaves glycosidic bonds in polygalacturonic acid by ⁇ -elimination
  • pectin lyase cleaves the glycosidic bonds of highly methylated pectins by ⁇ -elimination
  • polygalacturonase hydrolyses the glycosidic linkages in the polygalacturonic acid chain.
  • EP 388 593 discloses the recombinant production of an A. niger pectin esterase in A. awamori or A. niger.
  • Khanh et al. (1992) disclose the effect, on enzyme yield, of using various promoters in the expression of an A. niger pectin methyl esterase in A. niger.
  • van Rijssel et al. (1993) disclose a protein complex isolated from Clostridium thermosaccharolyticum which has pectin methylesterase activity.
  • WO 93/13212 discloses a tomato pectin esterase cDNA sequence.
  • WO 93/09683 discloses the use of a purified A. niger pectin esterase in the production of juice from fruits and vegetables.
  • PME pectin methylesterase
  • the present invention relates to an enzyme exhibiting PME activity, which enzyme
  • the invention relates to an enzyme exhibiting PME activity, which enzyme is encoded by a DNA sequence comprising the following partial sequence or a sequence homologous thereto encoding a polypeptide with PME activity.
  • the term "homologous" is intended to indicate a DNA which hybridizes to the same probe as the DNA coding for the PME enzyme under certain specified conditions (such as presoaking in 5xSSC and prehybridizing for 1 h at ⁇ 40°C in a solution of 5xSSC, 5xDenhardt's solution, 50 mM sodium phosphate, pH 6.8, and 50 ⁇ g of denatured sonicated calf thymus DNA, followed by hybridization in the same solution supplemented with 50 ⁇ Ci 32-P-dCTP labelled probe for 18 h at ⁇ 40°C followed by washing three times in 2xSSC, 0.2% SDS at 40°C for 30 minutes).
  • certain specified conditions such as presoaking in 5xSSC and prehybridizing for 1 h at ⁇ 40°C in a solution of 5xSSC, 5xDenhardt's solution, 50 mM sodium phosphate, pH 6.8, and 50 ⁇ g of denatured sonicated
  • the term is intended to refer to a DNA sequence which is at least 80% homologous to the sequence shown in SEQ ID No. 1, such as at least 85% and preferably at least 90% or 95% homologous to this sequence.
  • the term is intended to include modifications of the DNA sequences, such as nucleotide substitutions which do not give rise to another amino acid sequence of the PME but which correspond to the codon usage of the host organism into which the DNA construct is introduced or nucleotide substitutipns which do give rise to a different amino acid sequence and therefore, possibly, a different protein structure which might give rise to a PME mutant with different properties than the native enzyme.
  • Other examples of possible modifications are insertion of one or more nucleotides into the sequence, addition of one or more nucleotides at either end of the sequence, or deletion of one or more nucleotides at either end or within the sequence.
  • homologous polypeptide or protein is intended to indicate the degree of identity with the amino acid sequence shown in SEQ ID No. 2, which may be determined by methods known in the art. Furthermore, the homologous polypeptide is prefereably one which is encoded by an analogue (as defined above) of the DNA sequence shown in SEQ ID No. 1.
  • the invention relates to a DNA construct comprising a DNA sequence encoding an enzyme exhibiting pectin methyl esterase activity, which DNA sequence comprises the coding part of the DNA sequence shown in SEQ ID No. 1 or is an analogue of said sequence, which
  • the enzyme of the invention may be isolated by a general method involving
  • Example 1 A more detailed description of this screening method is given in Example 1 below.
  • the DNA sequence coding for the enzyme may for instance be isolated by screening a cDNA library of Aspergillus aculeatus, e.g strain CBS 101.43, publicly available from the Centraalbureau voor Schimmelcultures, Delft, NL, and selecting for clones expressing the appropriate enzyme activity (i.e. PME activity as defined by the ability of the enzyme to hydrolyse methylester bonds in pectin).
  • the appropriate DNA sequence may then be isolated from the clone by standard procedures, e.g. as described in Example 1.
  • DNA encoding a homologous enzyme may be isolated by similarly screening a cDNA library of another microorganism, in particular a fungus, such as a strain of an Aspergillus sp., in particular a strain of A. aculeatus, A. oryzae or A. niger, a strain of a Trichoderma sp., in particular a strain of T. harzianum or T. reesie , a strain of a Fusarium sp., in particular a strain of F. oxysporum, a strain of a Humicola sp. or a strain of a Geotricum sp.
  • a fungus such as a strain of an Aspergillus sp., in particular a strain of A. aculeatus, A. oryzae or A. niger, a strain of a Trichoderma sp., in particular a strain of T. harzianum or T. ree
  • the DNA coding for a PME of the invention may, in accordance with well-known procedures, conveniently be isolated from DNA from any of the above mentioned organisms by use of synthetic oligonucleotide probes, prepared on the basis of a DNA sequence disclosed herein.
  • the DNA sequence may subsequently be inserted into a recombinant expression vector.
  • This may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced.
  • the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid.
  • the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome(s) into which it has been integrated.
  • the DNA sequence encoding the PME should be operably connected to a suitable promoter and terminator sequence.
  • the promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
  • the procedures used to ligate the DNA sequences coding for the PME, the promoter and the terminator, respectively, and to insert them into suitable vectors are well known to persons skilled in the art (cf., for instance, Sambrook et al., Molecular Cloning. A Laboratory Manual, Cold Spring Harbor, NY, 1989).
  • the host cell which is transformed with the DNA sequence encoding the enzyme of the invention is preferably a eukaryotic cell, in particular a fungal cell such as a yeast or filamentous fungal cell.
  • the cell may belong to a species of Aspergillus , most preferably Aspergillus oryzae or Aspergillus niger.
  • Fungal cells may be transformed by a process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall in a manner known per se.
  • Aspergillus oryzae as a host microorganism is described in EP 238 023 (of Novo Industri A/S), the contents of which are hereby incorporated by reference.
  • the host cell may also be a yeast cell, e.g. a strain of Saccharomyces, in particular Saccharomyces cerevisiae.
  • the present invention relates to a method of producing an enzyme according to the invention, wherein a suitable host cell transformed with a DNA sequence encoding the enzyme is cultured under conditions permitting the production of the enzyme, and the resulting enzyme is recovered from the culture.
  • the medium used to culture the transformed host cells may be any conventional medium suitable for growing the host cells in question.
  • the expressed PME may conveniently be secreted into the culture medium and may be recovered therefrom by well-known procedures including separating the cells from the medium by centrifugation or filtration, precipitating proteinaceous components of the medium by means of a salt such as ammonium sulphate, followed by chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
  • the thus purified PME may be employed for immunization of animals for the production of antibodies. More specifically, antiserum against the PME of the invention may be raised by immunizing rabbits (or other rodents) according to the procedure described by N. Axelsen et al. in: A Manual of Quantitative Immunoelectrophoresis, Blackwell Scientific Publications, 1973, Chapter 23, or A. Johnstone and R. Thorpe, Immunochemistry in Practice, Blackwell Scientific Publications, 1982 (more specifically pp. 27-31). Purified immunoglobulins may be obtained from the antisera, for example by salt precipitation ((NH 4 ) 2 SO 4 ), followed by dialysis and ion exchange chromatography, e.g. on DEAE-Sephadex.
  • Immunochemical characterization of proteins may be done either by Outcherlony double-diffusion analysis (O. Ouchterlony in: Handbook of Experimental Immunology (D.M. Weir, Ed.), Blackwell Scientific Publications, 1967, pp. 655-706), by crossed immunoelectrophoresis (N. Axelsen et al. , supra , Chapters 3 and 4), or by rocket immunoelectrophoresis (N. Axelsen et al. , Chapter 2,).
  • the present invention relates to an enzyme preparation useful for the degradation of plant cell wall components, said preparation being enriched in an enzyme exhibiting PME activity as described above.
  • the enzyme preparation having been enriched with an enzyme of the invention may e.g. be an enzyme preparation comprising multiple enzymatic activities, in particular an enzyme preparation comprising multiple plant cell wall degrading enzymes such as Pectinex® or Pectinex Ultra SP® (Novo Nordisk A/S).
  • the term "enriched" is intended to indicate that the PME activity of the enzyme preparation has been increased, e.g. with an enrichment factor of at least 1.1, conveniently due to addition of an enzyme of the invention prepared by the method described above.
  • the enzyme preparation enriched in an enzyme exhibiting PME activity may be one which comprises an enzyme of the invention as the major enzymatic component, e.g. a mono-component enzyme preparation.
  • the enzyme preparation may be prepared in accordance with methods known in the art and may be in the form of a liquid or a dry preparation.
  • the enzyme preparation may be in the form of a granulate or a microgranulate.
  • the enzyme to be included in the preparation may be stabilized in accordance with methods known in the art.
  • a preferred use of the enzyme preparation according to the invention is as an agent for degradation or modification of plant cell wall material or other pectin containing material.
  • the enzyme of the invention may advantageously be used together with other enzymes, especially other pectin degrading enzymes when the enzyme is to be used in the processing of fruits, vegetables and other plant materials.
  • the enzyme preparation of the invention may in addition to the PME comprise one or more other plant cell wall degrading enzymes such as a polygalacturonase, pectin lyase, pectate lyase, arabinanase, xylanase, glucanase, galactanase, mannanase, rhamnogalacturonase, rhamnogalacturonan acetyl esterase or pectin acetylesterase.
  • the preparation may further contain one or more enzymes exhibiting exo-activity on the same substrates as the above-mentioned endo-enzymes.
  • the enzyme may be used in combination with polygalacturonase, pectate lyase or pectin lyase in pectin degradation.
  • an enzyme preparation of the invention comprising an enzyme exhibiting pectin methyl esterase activity, optionally in combination with one or more other enzymes.
  • the dosage of the enzyme preparation of the invention and other conditions under which the preparation is used may be determined on the basis of methods known in the art.
  • the enzyme preparation may advantageously be used for the treatment of pectin containing plant material, e.g. of vegetable or fruit origin, such as material obtained from soy beans, sugar beets or apples, so as to reduce the viscosity and thus improve the processing or appearance of the plant material in question.
  • the viscosity reduction may be obtained by treating the pectin-containing plant material with an enzyme preparation of the invention under suitable conditions for full or partial degradation of the pectin-containing material.
  • the enzyme preparation may be used for de-pectinization and viscosity reduction in vegetable or fruit juice, especially in apple or pear juice.
  • the enzyme preparation may be used in the treatment of mash from fruits and vegetables, for instance in the mash treatment of apples and pears for juice production, and in the mash treatment of grapes for wine production.
  • the enzyme preparation may be used in the production of citrus juice, e.g. for partial or complete degradation of the pulp present in the juice after pressing.
  • the enzyme preparation in addition to PME comprises a polygalacturonase containing enzyme preparation.
  • an enzyme preparation of the invention it is possible to regulate the consistency and appearance of processed fruit or vegetables.
  • the consistency and appearance have been found to be a product of the actual combination of enzymes used for the processing, i.e. the nature of the enzymes (especially pectin degrading enzyme(s)) with which the pectin methyl esterase of the invention is combined.
  • Examples of products with specific properties which may be produced by use of an enzyme preparation of the invention include clear juice from apples, pears or berries, cloud stable juice from apples, pears, berries, citrus, or tomatoes, and purees from carrots and tomatoes.
  • the PME of the invention may be produced as a single component essentially free from other enzyme activities such as polygalacturonase and/or pectin lyase activity normally found to be present in commercially available pectinesterase containing pectinolytic preparations.
  • Examples of such purposes include the use af the pectin methylesterase for full or partial demethylation of pectin in processed or non-processed fruits and vegetables.
  • the partial demethylation is, e.g., important when an improved firmness of fruits or vegetables is desirable. Thus, firmness is often reduced during processing (e.g. canning and pasteurization).
  • a controlled amount of a PME of the invention a partial demethylation of pectin present in the surface of fruits and vegetables may be obtained and the resulting partially demethylated pectin may crosslink with, e.g., divalent ions such as calcium, whereby a more firm surface of the fruits or vegetables may be formed.
  • the PME of the invention may be used for improving the firmness of, e.g., beans, peas and sliced fruits such as pears and apples.
  • pectin e.g. from citrus, apple, sunflower and/or sugar beet.
  • the PME can be used to produce low methylated pectin (defined as pectins where under 50% of the galacturonic acids are methylated) from high methylated pectin (defined as pectin where over 50% of the galacturoric acids are methylated).
  • pectins defined as pectins where under 50% of the galacturonic acids are methylated
  • pectin defined as pectin where over 50% of the galacturoric acids are methylated
  • the pectin esterase can be used to obtain an in situ viscosity increase or gel formation in various vegetable or fruit based products, when added together (simultaneously or non-simultaneously) with medium or high methylated pectin.
  • the resulting low methylated pectin will, in the presence of, e.g., divalent ions, form a more viscous liquid or a gel.
  • the natural content of pectin may be demethylated by use of the enzyme, whereby the addition of pectin may be reduced or even avoided.
  • PME for viscosity increase or gel formation eliminates or reduces the addition of other stabilizing or gelling agents in, e.g., jam and ketchup.
  • the demethoxylation of the natural content of pectin, which is induced by the enzyme may, upon reaction with the natural content of metal ions, be sufficient for a satisfactory viscosity increase or gelformation to take place.
  • the amount of pectin methyl esterase to be added is typically in the range 0.1-100 PMEU per g of pectin, particularly 1-10 PMEU per g.
  • the PME activity (PMEU) is defined in the Materials and Methods section below.
  • the PME of the invention can alone or together with other enzymes be used to improve the digestibility of pectin containing animal feed, e.g. feed prepared from soya beans, sugar beets or rape seeds.
  • an enzyme preparation of the invention is added to the feed.
  • the pectin esterase activity can together with other enzymes be used to produce monogalacturonic acid or galacturonic acid containing oligosaccharides from pectin-containing material such as sugar beet pulp in accordance with well-known methods.
  • Monogalacturonic acid may be used for production of galactaric acid or for production of fatty acid and fatty alcohol esters and/or ethers of galacturonic acid.
  • Galacturonic containing oligosaccharides may be used as additives for human food or animal feed.
  • the PME can in combination with other enzymes be used for the removal of pectic substances from plant fibres, which removal is essential, e.g. in the production of textile fibres or other cellulosic materials.
  • plant fibre material is treated with a suitable amount of the PME of the invention under suitable conditions for obtaining full or partial degradation of pectic substances associated with the plant fibre material.
  • Donor organism mRNA was isolated from Aspergillus aculeatus, CBS 101.43, grown in a soy-containing fermentation medium with agitation to ensure sufficient aeration. Mycelia were harvested after 3-5 days' growth, immediately frozen in liquid nitrogen and stored at -80°C.
  • Yeast strains The Saccharomyces cerevisiae strain used was yNG231 (MAT alpha, leu2, ura3-52, his4-539, pep4-delta 1, cir+) or JG169 (MAT ⁇ ; ura 3-52; leu 2-3, 112; his 3-D200; pep 4-113; prc1::HIS3; prb1:: LEU2; cir+).
  • Plasmid Construction of an expression plasmid The commercially available plasmid pYES II (Invitrogen) was cut with SpeI, filled in with Klenow DNA polymerase + dNTP and cut with ClaI. The DNA was size fractionated on an agarose gel, and a fragment of about 2000 bp was purified by electroelution. The same plasmid was cut with ClaI/PvuII, and a fragment of about 3400 bp was purified by electroelution. The two fragments were ligated to a blunt-ended SphI/EcoRI fragment containing the yeast TPI promoter. This fragment was isolated from a plasmid in which the TPI promoter from S. cerevisiae (cf. T. Albers and G.
  • RNA extraction buffer 4 M GuSCN, 0.5 % Na-laurylsarcosine, 25 mM Na-citrate, pH 7.0, 0.1 M ⁇ -mercaptoethanol. The mixture was stirred for 30 min.
  • RNA pellet was transferred into an Eppendorf tube, suspended in 500 ⁇ l TE, pH 7.6 (if difficult, heat occasionally for 5 min at 65 °C), phenol extracted and precipitated with ethanol for 12 h at - 20 °C (2.5 vols EtOH, 0.1 vol 3M NaAc, pH 5.2). The RNA was collected by centrifugation, washed in 70 % EtOH, and resuspended in a minimum volume of DEPC-DIW. The RNA concentration was determined by measuring OD 260/280 .
  • poly(A) + RNAs were isolated by oligo(dT)-cellulose affinity chromatography (Aviv & Leder, 1972). Typically, 0.2 g of oligo(dT) cellulose (Boehringer Mannheim) was preswollen in 10 ml of 1 x column loading buffer (20 mM Tris-Cl, pH 7.6, 0.5 M NaCl, 1 mM EDTA, 0.1 % SDS), loaded onto a DEPC-treated, plugged plastic column (Poly Prep Chromatography Column, Bio Rad), and equilibrated with 20 ml 1 x loading buffer.
  • 1 x column loading buffer (20 mM Tris-Cl, pH 7.6, 0.5 M NaCl, 1 mM EDTA, 0.1 % SDS
  • RNA sample was heated at 65°C for 8 min., quenched on ice for 5 min, and after addition of 1 vol 2 x column loading buffer to the RNA sample loaded onto the column.
  • the eluate was collected and reloaded 2-3 times by heating the sample as above and quenching on ice prior to each loading.
  • the oligo(dT) column was washed with 10 vols of 1 x loading buffer, then with 3 vols of medium salt buffer (20 mM Tris-Cl, pH 7.6, 0.1 M NaCl, 1 mM EDTA, 0.1 % SDS), followed by elution of the poly(A) + RNA with 3 vols of elution buffer (10 mM Tris-Cl, pH 7.6, 1 mM EDTA, 0.05 % SDS) preheated to + 65 °C, by collecting 500 ⁇ l fractions. The OD 260 was read for each. collected fraction, and the mRNA containing fractions were pooled and ethanol precipitated at - 20 °C for 12 h.
  • the poly(A) + RNA was collected by centrifugation, resuspended in DEPC-DIW and stored in 5-10 ⁇ g aliquots at - 80 °C.
  • Double-stranded cDNA was synthesized from 5 ⁇ g of A. aculeatus poly(A) + RNA by the RNase H method (Gubler & Hoffman 1983, Sambrook et al., 1989) using the hair-pin modification.
  • the poly(A) + RNA (5 ⁇ g in 5 ⁇ l of DEPC-treated water) was heated at 70 °C for 8 min., quenched on ice, and combined in a final volume of 50 ⁇ l with reverse transcriptase buffer (50 mM Tris-Cl, pH 8.3, 75 mM KCl, 3 mM MgCl2, 10 mM DTT, Bethesda Research Laboratories) containing 1 mM each dNTP (Pharmacia), 40 units of human placental ribonuclease inhibitor (RNasin, Promega), 10 ⁇ g of oligo(dT) 12-18 primer (Pharmacia) and 1000 units of Superscript II RNase H- reverse transcriptase (Bethesda Research Laboratories).
  • reverse transcriptase buffer 50 mM Tris-Cl, pH 8.3, 75 mM KCl, 3 mM MgCl2, 10 mM DTT, Bethesda Research Laborator
  • First-strand cDNA was synthesized by incubating the reaction mixture at 45 °C for 1 h.
  • Second strand synthesis After synthesis 30 ⁇ l of 10 mM Tris-Cl, pH 7.5, 1 mM EDTA was added, and the mRNA:cDNA hybrids were ethanol precipitated for 12 h at - 20 °C by addition of 40 ⁇ g glycogen carrier (Boehringer Mannheim) 0.2 vols 10 M NH 4 Ac and 2.5 vols 96 % EtOH.
  • Second strand cDNA synthesis was performed by incubating the reaction tube at 16 °C for 3 h, and the reaction was stopped by addition of EDTA to 20 mM final concentration followed by phenol extraction.
  • Mung bean nuclease treatment The double-stranded (ds) cDNA was ethanol precipitated at - 20 °C for 12 h by addition of 2 vols of 96 % EtOH, 0.1 vol 3 M NaAc, pH 5.2, recovered by centrifugation, washed in 70 % EtOH, dried (SpeedVac), and resuspended in 30 ⁇ l of Mung bean nuclease buffer (30 mM NaAc, pH 4.6, 300 mM NaCl, 1 mM ZnSO4, 0.35 mM DTT, 2 % glycerol) containing 36 units of Mung bean nuclease (Bethesda Research Laboratories).
  • the single-stranded hair-pin DNA was clipped by incubating the reaction at 30 °C for 30 min, followed by addition of 70 ⁇ l 10 mM Tris-Cl, pH 7.5, 1 mM EDTA, phenol extraction, and ethanol precipitation with 2 vols of 96 % EtOH and 0.1 vol 3M NaAc, pH 5.2 at - 20 °C for 12 h.
  • the ds cDNA was blunt-ended with T4 DNA polymerase in 50 ⁇ l of T4 DNA polymerase buffer (20 mM Tris-acetate, pH 7.9, 10 mM MgAc, 50 mM KAc, 1 mM DTT) containing 0.5 mM each dNTP and 7.5 units of T4 DNA polymerase (Invitrogen) by incubating the reaction mixture at + 37 °C for 15 min. The reaction was stopped by addition of EDTA to 20 mM final concentration, followed by phenol extraction and ethanol precipitation.
  • T4 DNA polymerase buffer 20 mM Tris-acetate, pH 7.9, 10 mM MgAc, 50 mM KAc, 1 mM DTT
  • Adaptor ligation and size selection After the fill-in reaction the cDNA was ligated to non-palindromic BstX I adaptors (1 ⁇ g/ ⁇ l, Invitrogen) in 30 ⁇ l of ligation buffer (50 mM Tris-Cl, pH 7.8, 10 mM MgCl2, 10 mM DTT, 1 mM ATP, 25 ⁇ g/ml bovine serum albumin) containing 600 pmol BstX I adaptors and 5 units of T4 ligase (Invitrogen) by incubating the reaction mix at + 16 °C for 12 h.
  • ligation buffer 50 mM Tris-Cl, pH 7.8, 10 mM MgCl2, 10 mM DTT, 1 mM ATP, 25 ⁇ g/ml bovine serum albumin
  • the reaction was stopped by heating at + 70 °C for 5 min, and the adapted cDNA was size-fractionated by agarose gel electrophoresis (0.8 % HSB-agarose, FMC) to separate unligated adaptors and small cDNAs.
  • the cDNA was size-selected with a cut-off at 0.7 kb, and the cDNA was electroeluted from the agarose gel in 10 mM Tris-Cl, pH 7.5, 1 mM EDTA for 1 h at 100 volts, phenol extracted and ethanol precipitated at - 20 °C for 12 h as above.
  • the cells were grown at + 37 °C for 1 h , 50 ⁇ l plated on LB + ampicillin plates (100 ⁇ g/ml) and grown at + 37 °C for 12h.
  • a large-scale ligation was set up in 40 ⁇ l of ligation buffer containing 9 units of T4 ligase, and the reaction was incubated at + 16 °C for 12 h.
  • the ligation reaction was stopped by heating at 70 °C for 5 min, ethanol precipitated at - 20 °C for 12 h, recovered by centrifugation and resuspended in 10 ⁇ l DIW.
  • One ⁇ l aliquots were transformed into electrocompetent E. coli 1061 cells using the same electroporation conditions as above, and the transformed cells were titered and the library plated on LB + ampicillin plates with 5000-7000 c.f.u./plate. To each plate was added 3 ml of medium.
  • the bacteria were scraped off, 1 ml glycerol was added and stored at -80°C as pools. The remaining 2 ml were used for DNA isolation. If the amount of DNA was insufficient to give the required number of yeast transformants, large scale DNA was prepared from 500 ml medium (TB) inoculated with 50 ⁇ l of -80°C bacterial stock propagated overnight.
  • TB medium
  • yeast transformants To ensure that all the bacterial clones were tested in yeast, a number of yeast transformants 5 times larger than the number of bacterial clones in the original pools was set as the limit.
  • the vector pHD414 is a derivative of the plasmid p775 (described in EP 238 023). In contrast to this plasmid, pHD 414 has a string of unique restriction sites between the promoter and the terminator. The plasmid was constructed by removal of an approximately 200 bp long fragment (containing undesirable RE sites) at the 3'end of the terminator, and subsequent removal of an approximately 250 bp long fragment at the 5'end of the promoter, also containing undesirable sites.
  • the 200 bp region was removed by cleavage with NarI (positioned in the pUC vector) and XbaI (just 3' to the terminator), subsequent filling in the generated ends with Klenow DNA polymerase +dNTP, purification of the vector fragment on gel and religation of the vector fragment.
  • This plasmid was called pHD413.
  • pHD413 was cut with StuI (positioned in the 5'end of the promoter) and PvuII (in the pUC vector), fractionated on gel and religated.
  • the plasmid pHD 414 is shown in Fig. 2.
  • YPD 10 g yeast extract, 20 g peptone, H 2 O to 810 ml. Autoclaved, 90 ml 20% glucose (sterile filtered) added.
  • SC-URA 90 ml 10 x Basal salt, 22.5 ml 20 % casamino acids, 9 ml 1% tryptophan, H 2 O ad 806 ml, autoclaved, 3.6 ml 5% threonine and 90 ml 20% glucose or 20% galactose added.
  • SC-H broth 7.5 g/l yeast nitrogen base without amino acids, 11.3 g/l succinic acid, 6.8 g/l NaOH, 5.6 g/l casamino acids without vitamins, 0.1 g/l tryptophan.
  • SC-H agar 7.5 g/l yeast nitrogen base without amino acids, 11.3 g/l succinic acid, 6.8 g/l NaOH, 5.6 g/l casamino acids without vitamins, 0.1 g/l tryptophan, and 20 g/l agar (Bacto). Autoclaved for 20 min. at 121°C. After autoclaving, 55 ml of a 22% galactose solution and 1.8 ml of a 5% threonine solution were added per 450 ml agar.
  • YNB-1 agar 3.3 g/l KH 2 PO 4 , 16.7 g/l agar, pH adjusted to 7. Autoclaved for 20 min. at 121°C. After autoclaving, 25 ml of a 13.6% yeast nitrogen base without amino acids, 25 ml of a 40% glucose solution, 1.5 ml of a 1% L-leucine solution and 1.5 ml of a 1% histidine solution were added per 450 ml agar.
  • YNB-1 broth Composition as YNB-1 agar, but without the agar.
  • FG-4-Agar 35 g/L agar, 30 g/L Soy bean meal, 15 g/L maltodextrin (Glucidex 6), 5 g/L Bacto pepton, pH 7. Autoclaved 40 min at 121°C
  • FG-4 medium 30 g/L Soy bean meal, 15 g/L maltodextrin (Glucidex 6), 5 g/L Bacto peptone. Autoclaved 40 min at 121°C.
  • MDU-2 medium 45 g/L maltose, 1 g/L MgSO 4 - 7 H 2 O, 1 g/L NaCl, 2g/L K 2 SO 4 , 12 g/L KH 2 PO 4 , 0.1 ml/L Pluronic 61 L, 0.5 ml/L Trace metal solution. pH 5.0. Autoclaved 20 min at 121°C. 15 ml/L 50% sterile filtered urea is added after autoclaving.
  • Pectin overlayer gel 1% HSB agarose, 1% pectin (DE 75%) in a buffer with an appropriate pH. The gel was boiled and then cooled to 55°C before the overlayer was poured onto agar plates.
  • YPD Yeast et al., Methods in Yeast Genetics, Cold Spring Harbor Laboratory, 1981
  • the mycelium is harvested by filtration through miracloth and washed with 200 ml of 0.6 M MgSO 4 .
  • the suspension is cooled on ice and 1 ml of buffer containing 120 mg of Novozym® 234, batch 1687 is added.
  • Protoplasts are spread on the appropriate plates.
  • Fed batch fermentation was performed in a medium comprising maltodextrin as a carbon source, urea as a nitrogen source and yeast extract.
  • the fed batch fermentation was performed by innoculating a shake flask culture of A. oryzae host cells in question into a medium comprising 3.5% of the carbon source and 0.5% of the nitrogen source. After 24 hours of cultivation at pH 5.0 and 34°C the continuous supply of additional carbon and nitrogen sources were initiated. The carbon source was kept as the limiting factor and it was secured that oxygen was present in excess.
  • the fed batch cultivation was continued for 4 days, after which the enzymes could be recovered by centrifugation, ultrafiltration, clear filtration and germ filtration.
  • the recombinant enzyme from A. oryzae was purified as follows: A culture supernatant was harvested after 5 days of culture, and centrifuged, sterile filtered, and concentrated on a 20 kDa ultrafiltration device to approximately 20% dry matter. 40 ml of this concentrate (containing 80-120 mg rPME) were diluted 10 times in 20 mM Tris pH 8.0 and applied to a HR 16/20 Q-Sepharose fast flow column (Pharmacia, Sweden) at 1.5 ml/min, and eluted with a linear NaCl gradient (from 0 to 0.6M NaCl) at approximately 0.4 M NaCl.
  • the fractions containing pectin methyl esterase activity were pooled and ultrafiltrated into 20 mM citrate pH 3.0 and loaded on a HR 16/20 S-Sepharose fast flow column (Pharmacia, Sweden) at 1.5 ml/min, and eluted with a linear NaCl gradient at approximately 0.2 M NaCl.
  • the fractions containing PME activity were ultrafiltrated in water and used for characterization as described below. Protein concentrations in the fractions were determined by the Bio Rad protein assay (Bio Rad, USA).
  • SDS-PAGE electrophoresis was performed in a Mini-Leak 4 electrophoresis unit (Kem-En-Tec, Denmark) as a modified version of the Laemli procedure (Laemmli 1970). Isoelectric focusing was carried out on Ampholine PAG plates pH 3.5 - 9.5 (Pharmacia, Sweden) on a Multiphor electrophoresis unit according to the manufactures instructions. Gels were either silverstained essentially as described in (Merrild, Switzer et al. 1979) or coomassie stained according to (Matsudaira 1989).
  • the equipment used was a titrator TTT80; autoburette ABU80; Titrigraph module REA 160; pH stat unit REA 270 all manufactured by Radiometer, Copenhagen, Denmark.
  • the incubations were done in a 15 ml reactor cell connected to a thermostat and a magnetic stirrer.
  • the reactor was filled with 15 ml 0.2% substrate solution in water, the substrate being apple pectin with a 75% of esterification produced from apple pectin manufactured by Obipektin AG. pH was adjusted to 4.5 with NaOH or HCl (for determination of pH optimum, pH was adjusted to other values as described below), and the temperature of the reaction cell was maintained at 30°C (except for determination of temperature optimum, as described below).
  • n(hmel) n(NaOH) (1+[H+]/Ka*)) *)
  • the pK a of galacturonic acid is approximately 3.5 at 30°C.
  • the enzyme samples were incubated at various temperatures between 30°C and 80°C for 0.1 and 2 hours, after which the activity was measured as described above.
  • 1 unit of pectin methyl esterase activity is defined as the amount of pectin methyl esterase which hydrolyzes 1 ⁇ mole of pectin methyl ester per minute wtih citrus pectin (72 % methylation) as the substrate at 0.5 % by weight substrate concentration at pH 4.8 and 22°C.
  • DNA was isolated from 20 individual clones from the library and subjected to analysis for cDNA insertion.
  • the insertion frequency was found to be >90 % and the average insert size was approximately 1400bp.
  • DNA from some of the pools was transformed into yeast, and 50-100 plates containing 200-500 yeast colonies were obtained from each pool. After 3-5 days of growth, the agar plates were replica plated onto several sets of agar plates. One set of plates was then incubated for 2-4 days at 30°C and overlayered with a pectin overlayer gel for detection of pectinolytic activity. After incubation overnight at 30°C, 10-15 ml of a 1% solution of MTAB (mixed alkyltrimethylammonium bromide) was poured onto the overlayer and removed after 1 hour. PME positive colonies were identified as colonies surrounded by a white halo.
  • MTAB mixed alkyltrimethylammonium bromide
  • the positive clones were obtained as single colonies, the cDNA inserts were amplified directly from the yeast colony using biotinylated polylinker primers, purified by magnetic beads (Dynabead M-280, Dynal) system and characterized individually by sequencing the 5'-end of each cDNA clone using the chain-termination method (Sanger et al., 1977) and the Sequenase system (United States Biochemical).
  • the cDNA sequence encoding the enzyme is shown in SEQ ID no. 1.
  • PME-producing colonies were inoculated into 20 ml YNB-1 broth in a 50 ml glass test tube. The tube was shaken for 2 days at 30°C. The cells were harvested by centrifugation for 10 min. at 3000 rpm.
  • the cells were resuspended in 1 ml 0.9 M sorbitol, 0.1 M EDTA, pH 7.5. The pellet was transferred to an Eppendorf tube, and spun for 30 seconds at full speed. The cells were resuspended in 0.4 ml 0.9 M sorbitol, 0.1 M EDTA, 14 mM ⁇ -mercaptoethanol. 100 ⁇ l 2 mg/ml Zymolase was added, and the suspension was incubated at 37°C for 30 minutes and spun for 30 seconds. The pellet (spheroplasts) was resuspended in 0.4 ml TE.
  • the DNA was transformed into E. coli by standard procedures. Two E. coli colonies were isolated from each of the transformations and analysed with the restriction enzymes HindIII and XbaI which excised the DNA insert. DNA from one of these clones was retransformed into yeast strain JG169.
  • the DNA sequences of several of the positive clones were determined. The entire DNA sequence of a PME is shown in SEQ ID No. 1, a partial DNA sequence is shown in SEQ ID No. 3.
  • cDNA is isolated from one or more representatives of each family by digestion with HindIII/XbaI or other appropriate restriction enzymes, size fractionation on a gel and purification and subsequently ligated to pHD414, resulting in the plasmid pA1PE1.2. After amplification in E. coli, the plasmids are transformed into A. oryzae or A. niger according to the general procedure described above.
  • Each of the transformants was inoculated in the center of a Petri dish with FG-4 agar. After 5 days of incubation at 30°C 4 mm diameter plugs were removed from the center of the colonies by a corkscrew. The plugs were embedded in a pectin overlayer gel and incubated overnight at 40°C. The PME activity was identified as described above. Some of the transformants had halos which were significantly larger than the A. oryzae background. This demonstrates efficient expression of PME in A. oryzae. The 8 transformants with the highest PME activity were selected and inoculated and maintained on YPG-agar.
  • Each of the 8 selected transformants were inoculated from YPG-agar slants on 500 ml shake flask with FG-4 and MDU-2 media. After 3-5 days of fermentation with sufficient agitation to ensure good aeration, the culture broths were centrifuged for 10 minutes at 2000 g and the supernatants were analyzed.
  • a volume of 15 ⁇ l of each supernatant was applied to 4 mm diameter holes punched out in a pectin overlayer gel (25 ml in a 13 cm diameter Petri dish).
  • the PME activity was identified by the formation of a white halo on incubation.
  • the PME was produced by fed batch fermentation of A. oryzae expressing the enzyme as described in Materials and Methods above.
  • PME hydrolyzes the ester-linkage between methanol and galacturonic acid in esterified pectin.
  • the action of the enzyme can be measured by the decrease in pH which happens concomitant with the formation of free acid groups.
  • This analysis method has been used for determination of Km, Vmax, pH & Temperature optimum of a PME of the invention as well as determination of how temperature, pH and substrate concentration affects the activity of the enzyme.
  • the molecular weight of the enzyme was determined to 43 kD by SDS-PAGE. This is higher than the calculated molecular weight of the enzyme (approx. 35 kD) indicating that the enzyme may be glycosylated to a significant extent.
  • the isoelectric point was determined to 3.8 by isoelectric focusing, which is slightly lower than the calculated value (4.1). This may also indicate that the enzyme undergoes a significant post-translational processing (e.g. glycosylation).
  • the pH optimum was measured to approximately pH 4.5 (Fig. 3) and the temperature optimum to 45°C (Fig. 4).
  • the activity drops sharply at pH above 4.5 and temperatures above 50°C, whereas the drop in activity at lower temperatures and pH was less pronounced.
  • the special method of measuring pH stability precludes an exact measurement of pH sensitivity of the enzyme, but the PME of the invention appears to be most stable at neutral pH, i.e. above 5.5-6 such as within pH 6-8 (Fig. 5).
  • the enzyme was relatively sensitive to elevated temperatures, i.e. temperatures above 50°C. Already after 1 hour at 50°; almost 80% of the activity has been lost (Fig. 6).
  • K m was measured to 2.8% on 75% esterified apple pectin (apple pectin, with a 75% degree of esterification). This is a relatively high value, which indicates a relatively low affinity to the substrate.
  • the maximal velocity of the enzyme, V max was determined to 8.6 ⁇ mol/min, and the specific activity was determined to 5.5 mmol/(min/mg).
  • the enzyme was not able to hydrolyze acetyl-ester groups from neither acetylated polysaccharides, nor the synthetic acetylesterase substrate p-nitro-phenol-acetate, demonstrating its substrate specificity.
  • the specific activity on apple pectin of 5.5 mmol/(min/mg) indicates that the enzyme has a very high catalytic capacity.
  • the acidic pH optimum of the enzyme indicates that it may be of great value in fruit juice processing where the pH frequently is below pH 5.0, but it may also be of use in the wine, feed and food industry, where pectin containing plant material is processed.
  • pectin having a degree of esterification of 72% were diluted in 2000 mls, 80°C demineralized water.
  • the pectin solution was tempered to 30°C, pH was adjusted to 4.5 with 0.25 M NaHCO 3 .
  • Oranges were washed and minced in a meat chopping machine. The fruit was added sugar in the level fruit/sugar: 5/1 based on weight. Then the fruit mass was cooked for about 15 min and cooled to -18°C.
  • the fruit mass was later diluted 1:1 by demineralized water, tempered to 40°C and pectin methyl esterase prepared as described above was added to 50 g samples in amounts of 17, 1.7 and 0.17 PMEU/g of pectin.
  • the pH of the samples remained unajusted 3.5.
  • the pectin was estimated to be 30% w/w of the fruit.
  • a control was also prepared, consisting of 17 PMEU/g of pectin (inactivation 85°C for 3 minutes). The reaction time was 1 hour.
  • the samples were then cooled to 4°C over night and the following day the hardness of the gels was evaluated at 4°C, before and after a heat treatment (85°C for 3 min) of the samples.
  • the measurement of the hardness of the gels was carried out by using SMS Texture Analyser.
  • the conditions of the texture analysis were as follows: Probe, diameter mm 20 Penetration 20% Rate 2 mm/sek
  • Pectin methyl esterase prepared as described above was added to a portion of 100 g in an amount of 5 PMEU/g tomato product, a control was added 5 PMEU of inactivated PME/g tomato product.
  • the samples were mixed and left for 40°C for 30 minutes. The samples were then placed at 4°C until the next day and measured by SMS Texture Analyser at 17°C. The samples were heat treated for 85°C in 3 min to inactivate the enzyme and after having adjusted the temperature to 17°C, the samples were again measured by SMS Texture Analyser.
  • the texure analyser measures the hardness, N.
  • the probe is a 20 mm probe, penetration of the sample was 20%, the speed was 2 mm/sek.
  • test sample containing active enzyme gelled in 10 min while the control remained fluent.
  • the A. aculeatus pectin methylesterase sequence The A. aculeatus pectin methylesterase sequence.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)

Claims (21)

  1. Enzym, das Pektinmethylesterase-Aktivität aufweist, das
    a) von dem kodierenden Teil der in SEQ ID NO: 1 gezeigten DNA-Sequenz kodiert wird, und/oder
    b) die in SEQ ID NO: 2 gezeigte Aminosäuresequenz hat oder eine Sequenz, die wenigstens zu 80 % homolog dazu ist.
  2. Enzym, das Pektinmethylesterase-Aktivität aufweist, das von einer DNA-Sequenz kodiert wird, die die folgende Teilsequenz umfasst:
  3. Enzym nach einem beliebigen der Ansprüche 1 oder 2, das eine oder mehrere der folgenden Eigenschaften hat:
    - ein pH-Optimum von 4,5, wie bei 30 °C bestimmt, wobei zu 75 % verestertes Pektin als Substrat verwendet wird;
    - ein Temperaturoptimum von 45 °C, wobei zu 75 % verestertes Pektin als Substrat verwendet wird,
    - ein Molekulargewicht von 43 kD, das mittels SDS-PAGE bestimmt wird.
  4. Enzym nach einem beliebigen der Ansprüche 1 bis 3, das von einem Mikroorganismus ableitbar ist.
  5. Enzym nach Anspruch 4, das von einem filamentösen Pilz oder einer Hefe ableitbar ist.
  6. Enzym nach Anspruch 5, das von einem Stamm von Aspergillus, Trichoderma, Penicillium, Fusarium oder Humicola ableitbar ist.
  7. Enzym nach Anspruch 6, wobei das Enzym von einem Aspergillus-Stamm ableitbar ist, insbesondere einem Stamm von Aspergillus aculeatus, Aspergillus niger oder Aspergillus oryzae.
  8. Enzym nach Anspruch 7, das von der aus einer DNA-Bibliothek von Aspergillus aculeatus CBS 101.43 isolierten DNA-Sequenz kodiert wird.
  9. DNA-Konstrukt, das eine DNA-Sequenz umfasst, die ein Enzym kodiert, das Pektinmethylesterase-Aktivität aufweist, das
    i) mit einer auf der Grundlage der in SEQ ID NO: 1 gezeigten DNA-Sequenz hergestellten Oligonukleotidsonde unter den folgenden Bedingungen hybridisiert: Benetzen in 5xSSC und Prähybridisieren für 1 h bei ∼ 40 °C in einer Lösung von 5xSSC, 5xDenhardts Lösung, 50 mM Natriumphosphat, pH 6,8 und 50 µg denaturierter mit Ultraschall behandelter Kalbsthymus-DNA, gefolgt von Hybridisieren in der gleichen Lösung, der 50 µCi mit 32-P-dCTP-markierte Sonde zugesetzt wurden, für 18 h bei ∼ 40 °C, gefolgt von dreimaligem Waschen in 2xSSC, 0,2 % SDS bei 40 °C für 30 Minuten, und/oder
    ii) ein Enzym kodiert, das eine Aminosäuresequenz umfasst, die wenigstens zu 80 % homolog zu der in SEQ ID NO: 2 gezeigten Aminosäuresequenz ist.
  10. Rekombinanter Expressionsvektor, der das DNA-Konstrukt nach Anspruch 9 umfasst oder eine DNA-Sequenz, die ein Enzym nach einem beliebigen der Ansprüche 1-8 kodiert.
  11. Zelle, die einen rekombinanten Expressionsvektor nach Anspruch 10 umfasst.
  12. Zelle nach Anspruch 11, die eine eukaryontische Zelle ist, insbesondere eine Pilzzelle, wie eine Hefezelle oder eine filamentöse Pilzzelle.
  13. Zelle nach Anspruch 12, die zu einem Stamm von Aspergillus gehört, insbesondere von Aspergillus niger oder Aspergillus oryzae.
  14. Verfahren zur Produktion eines Enzyms, das Pektinmethylesterase-Aktivität aufweist, wobei das Verfahren Kultivieren einer Zelle nach einem beliebigen der Ansprüche 11-13 unter Bedingungen, die die Produktion des Enzyms erlauben, und Gewinnen des Enzyms von der Kultur umfasst.
  15. Enzymzubereitung, die für die Modifikation von pflanzlichen Zellwandkomponenten geeignet ist, in der ein Enzym angereichert ist, das Pektinmethylesterase-Aktivität nach einem beliebigen der Ansprüche 1-8 aufweist.
  16. Zubereitung nach Anspruch 15, die zusätzlich ein oder mehrere pflanzliche Zellwand abbauende Enzyme umfasst, wie Pektinlyase, Pektatlyase, Arabinanase, Xylanase, Glucanase, Galaktanase, Mannanase, Rhamnogalakturonase, Rhamnogalakturonan-Acetylesterase, Pektinacetylesterase, Polygalakturonase oder Pektinmethylesterase.
  17. Verwendung einer Pektinmethylesterase nach einem beliebigen der Ansprüche 1-8 zur Verbesserung der Festigkeit eines Pektin enthaltenden Materials.
  18. Verwendung einer Pektinmethylesterase nach einem beliebigen der Ansprüche 1-8 für die Demethylierung von Pektin.
  19. Verwendung einer Pektinmethylesterase nach einem beliebigen der Ansprüche 1-8 zur Erhöhung der Viskosität eines Pektin enthaltenden Materials.
  20. Verwendung nach Anspruch 18, wobei das Pektin enthaltende Material ein Frucht- oder Gemüsematerial ist.
  21. Verwendung nach Anspruch 18, wobei das Pektin enthaltende Material Milch ist, die zugesetztes Pektin umfasst.
EP94914350A 1993-04-30 1994-04-28 Ein enzym mit pektin methylesteraseaktivität Expired - Lifetime EP0696319B1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DK48793 1993-04-30
DK487/93 1993-04-30
DK48793A DK48793D0 (da) 1993-04-30 1993-04-30 Enzym
DK121793A DK121793D0 (da) 1993-10-28 1993-10-28 Enzym
DK121793 1993-10-28
DK1217/93 1993-10-28
PCT/DK1994/000173 WO1994025575A1 (en) 1993-04-30 1994-04-28 An enzyme exhibiting pectin methylesterase activity

Publications (2)

Publication Number Publication Date
EP0696319A1 EP0696319A1 (de) 1996-02-14
EP0696319B1 true EP0696319B1 (de) 2003-01-29

Family

ID=26064093

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94914350A Expired - Lifetime EP0696319B1 (de) 1993-04-30 1994-04-28 Ein enzym mit pektin methylesteraseaktivität

Country Status (9)

Country Link
US (1) US5707847A (de)
EP (1) EP0696319B1 (de)
AT (1) ATE231914T1 (de)
AU (1) AU679746B2 (de)
DE (1) DE69432073T2 (de)
DK (1) DK0696319T3 (de)
ES (1) ES2191030T3 (de)
PT (1) PT696319E (de)
WO (1) WO1994025575A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008024778A1 (de) * 2008-05-23 2009-11-26 Ab Enzymes Gmbh Verwendung von pektinolytischen Enzymen zur Behandlung von Obst- und Gemüsemaische und Enzymsequenzen dazu

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2301103B (en) * 1995-05-23 1999-12-22 Danisco An enzyme system comprising ferulic acid esterase
GB9514438D0 (en) * 1995-07-14 1995-09-13 Danisco Stabilisation process and an enzyme for use in such a process
WO1997027221A1 (en) * 1996-01-26 1997-07-31 Novo Nordisk A/S Enzymatic gelling of polymeric materials
AU1719497A (en) * 1996-02-21 1997-09-10 Novo Nordisk A/S An enzyme with pectin esterase activity
EP0892610A1 (de) * 1996-04-12 1999-01-27 Unilever Plc Verfahren zur herstellung eines nahrungsmittels
US5869122A (en) * 1996-05-24 1999-02-09 Nestec S.A. Treatment of fruits and vegetables
GB9708278D0 (en) 1997-04-24 1997-06-18 Danisco Composition
GB9817805D0 (en) 1998-08-14 1998-10-14 Danisco Use of a composition
GB2342921A (en) * 1998-10-24 2000-04-26 Zylepsis Ltd Demethoxylation of pectins, plant extracts containing PME and the uses thereof
US6221419B1 (en) 1998-11-05 2001-04-24 Hercules Incorporated Pectin for stabilizing proteins
GB9914210D0 (en) 1999-06-17 1999-08-18 Danisco Promoter
US6428837B1 (en) 2000-06-09 2002-08-06 Cp Kelco Aps Deesterified pectins, processes for producing such pectins, and stabilized acidic liquid systems comprising the same
EP1162259A1 (de) * 2000-06-09 2001-12-12 Danstar Ferment AG Enzymmischungen enthaltend ein Enzym mit Beta-Glucanaseaktivität, ihre Verwendung zur Verminderung oder Vermeidung von Gushing
US6699977B1 (en) 2000-06-09 2004-03-02 Cp Kelco Aps Low methoxyl pectins, processes thereof, and stabilized aqueous systems comprising the same
US20040235725A1 (en) * 2001-08-31 2004-11-25 Peter Albersheim Methods for making pectin-based mixed polymers
WO2005123136A1 (ja) * 2004-06-15 2005-12-29 Hisamitsu Pharmaceutical Co., Inc. 消炎鎮痛外用剤
JP4625318B2 (ja) * 2004-12-06 2011-02-02 財団法人野田産業科学研究所 相同組換え頻度が上昇した形質転換菌
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200694A (en) * 1977-10-08 1980-04-29 Kikkoman Shoyu Co., Ltd. Novel pectin esterase, process for its production, and process for producing demethoxylated pectin by the use of said pectin esterase
US6271033B1 (en) * 1986-11-11 2001-08-07 Zeneca Limited Method for modifying production of fruit ripening enzyme
DE3908813A1 (de) * 1989-03-17 1990-09-20 Roehm Gmbh Verfahren zur expression eines aus aspergillus niger stammenden gens in einem aspergillus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008024778A1 (de) * 2008-05-23 2009-11-26 Ab Enzymes Gmbh Verwendung von pektinolytischen Enzymen zur Behandlung von Obst- und Gemüsemaische und Enzymsequenzen dazu
US8748149B2 (en) 2008-05-23 2014-06-10 Ab Enzymes Gmbh Use of pectinolytic enzymes for the treatment of fruit and vegetable mash and enzyme sequences therefor

Also Published As

Publication number Publication date
DE69432073T2 (de) 2004-01-22
PT696319E (pt) 2003-06-30
ES2191030T3 (es) 2003-09-01
DE69432073D1 (de) 2003-03-06
EP0696319A1 (de) 1996-02-14
DK0696319T3 (da) 2003-05-19
AU679746B2 (en) 1997-07-10
AU6676794A (en) 1994-11-21
US5707847A (en) 1998-01-13
ATE231914T1 (de) 2003-02-15
WO1994025575A1 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
EP0696319B1 (de) Ein enzym mit pektin methylesteraseaktivität
EP0675951B1 (de) Enzym mit endoglukanase wirkung
US5795764A (en) Enzyme exhibiting mannanase activity
EP0635053B1 (de) Rhamnogalacturonan acetylesterase (RGAE) von Aspergillus aculeatus
US6329185B1 (en) Enzyme with galactanase activity
US6242237B1 (en) Enzyme with galactanase activity
US5830734A (en) Enzyme with acetyl esterase activity
US5723328A (en) Enzyme with endoglucanase activity
US6159718A (en) Enzyme with polygalacturonase activity
US5624835A (en) Endo-β-1,4-glucanase and a DNA sequence
EP0885295B1 (de) Enzym mit pektin-esterase-aktivität
US5474922A (en) β-1,4-galactanase and a DNA sequence
US5882911A (en) Enzyme with rhamnogalacturonase activity
US5858760A (en) Enzyme with pectin lyase activity
WO1994020611A1 (en) An enzyme with arabinanase activity

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951130

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19991025

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVOZYMES A/S

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69432073

Country of ref document: DE

Date of ref document: 20030306

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030428

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: R. A. EGLI & CO. PATENTANWAELTE

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Ref country code: GR

Ref legal event code: EP

Ref document number: 20030401279

Country of ref document: GR

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20030416

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2191030

Country of ref document: ES

Kind code of ref document: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20031030

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20080318

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20080312

Year of fee payment: 15

Ref country code: ES

Payment date: 20080429

Year of fee payment: 15

Ref country code: DK

Payment date: 20080430

Year of fee payment: 15

Ref country code: DE

Payment date: 20080502

Year of fee payment: 15

Ref country code: CH

Payment date: 20080502

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20080313

Year of fee payment: 15

Ref country code: AT

Payment date: 20080410

Year of fee payment: 15

REG Reference to a national code

Ref country code: DK

Ref legal event code: EAP

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20080429

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20080408

Year of fee payment: 15

Ref country code: NL

Payment date: 20080403

Year of fee payment: 15

Ref country code: IE

Payment date: 20080418

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20080430

Year of fee payment: 15

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF THE APPLICANT RENOUNCES

Effective date: 20080910

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20080418

Year of fee payment: 15

BERE Be: lapsed

Owner name: *NOVOZYMES A/S

Effective date: 20090430

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20091028

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

EUG Se: european patent has lapsed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20090428

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20091101

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20091231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090430

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091103

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090430

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090428

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091028

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090428

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090428

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091222

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090430

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20090429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091104

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090429